Carole Ho - Dec 6, 2021 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Chief Medical Officer
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Dec 6, 2021
Transactions value $
-$62,760
Form type
4
Date filed
12/8/2021, 04:35 PM
Previous filing
Aug 25, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$62.8K -1.48K -1.9% $42.52 76.3K Dec 6, 2021 Direct F1, F2
holding DNLI Common Stock 25K Dec 6, 2021 See footnote F3
holding DNLI Common Stock 159K Dec 6, 2021 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2 Includes 75,906 restricted stock units.
F3 The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
F4 The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.